ClinicalTrials.govpublic full text
UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
multiple myeloma, measles virus, sodium iodide symporter, cyclophosphamide, refractory multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855479
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.